SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$47.64
+0.88 (+1.88%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-6.92%
1Y
+17.43%
YTD
-3.70%
Open$47.00
Previous Close$46.76
Day High$47.88
Day Low$46.43
52W High$59.68
52W Low$38.26
Volume—
Avg Volume1.44M
Market Cap2.72B
P/E Ratio—
EPS$-1.91
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.76
Below
SMA 200
$43.00
Above
RSI (14)
59.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+90.7% upside
Current
$47.64
$47.64
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 726.62M | 708.76M | 1.12B |
| Net Income | -38,961,692 | -34,203,592 | 218.96M |
| Profit Margin | -5.4% | -5.1% | 19.5% |
| EBITDA | 27.47M | 25.45M | 345.29M |
| Free Cash Flow | — | — | 147.80M |
| Rev Growth | +2.5% | +2.5% | +10.9% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |